| Dexamethasone | Approved Investigational Vet Approved | COL10A1 | 1300 |
upregulated | Dexamethasone results in increased expression of COL10A1 mRNA | 6q22.1 | |
| Dexamethasone | Approved Investigational Vet Approved | COL12A1 | 1303 |
downregulated | Dexamethasone results in decreased expression of COL12A1 mRNA | 6q13-q14.1 | |
| Dexamethasone | Approved Investigational Vet Approved | COL13A1 | 1305 |
downregulated | Dexamethasone results in decreased expression of COL13A1 mRNA | 10q22.1 | |
| Dexamethasone | Approved Investigational Vet Approved | COL14A1 | 7373 |
downregulated | Dexamethasone results in decreased expression of COL14A1 mRNA | 8q24.12 | |
| Dexamethasone | Approved Investigational Vet Approved | COL15A1 | 1306 |
downregulated | Dexamethasone results in decreased expression of COL15A1 mRNA | 9q22.33 | |
| Dexamethasone | Approved Investigational Vet Approved | COL1A2 | 1278 |
downregulated | Dexamethasone results in decreased expression of COL1A2 mRNA | 7q21.3 | |
| Dexamethasone | Approved Investigational Vet Approved | COL2A1 | 1280 |
downregulated | Dexamethasone results in decreased expression of COL2A1 mRNA | 12q13.11 | |
| Dexamethasone | Approved Investigational Vet Approved | COL3A1 | 1281 |
downregulated | Dexamethasone results in decreased expression of COL3A1 mRNA | 2q32.2 | |
| Dexamethasone | Approved Investigational Vet Approved | COL4A1 | 1282 |
upregulated | Dexamethasone results in increased expression of COL4A1 mRNA | 13q34 | |
| Dexamethasone | Approved Investigational Vet Approved | COL5A1 | 1289 |
downregulated | Dexamethasone results in decreased expression of COL5A1 mRNA | 9q34.3 | |
| Dexamethasone | Approved Investigational Vet Approved | COL5A2 | 1290 |
downregulated | Dexamethasone results in decreased expression of COL5A2 mRNA | 2q32.2 | |
| Dexamethasone | Approved Investigational Vet Approved | COL6A2 | 1292 |
downregulated | Dexamethasone results in decreased expression of COL6A2 mRNA | 21q22.3 | |
| Dexamethasone | Approved Investigational Vet Approved | COL6A3 | 1293 |
downregulated | Dexamethasone results in decreased expression of COL6A3 mRNA | 2q37.3 | |
| Dexamethasone | Approved Investigational Vet Approved | COL7A1 | 1294 |
downregulated | Dexamethasone results in decreased expression of COL7A1 mRNA | 3p21.31 | |
| Dexamethasone | Approved Investigational Vet Approved | COX7A1 | 1346 |
upregulated | Dexamethasone results in increased expression of COX7A1 mRNA | 19q13.12 | |
| Dexamethasone | Approved Investigational Vet Approved | CPNE7 | 27132 |
upregulated | Dexamethasone results in increased expression of CPNE7 mRNA | 16q24.3 | |
| Dexamethasone | Approved Investigational Vet Approved | CRYAB | 1410 |
upregulated | Dexamethasone results in increased expression of CRYAB mRNA | 11q23.1 | |
| Dexamethasone | Approved Investigational Vet Approved | CRYBB2P1 | 1416 |
downregulated | Dexamethasone results in decreased expression of CRYBB2P1 mRNA | 22q11.2-q12.1 | |
| Dexamethasone | Approved Investigational Vet Approved | CS | 1431 |
upregulated | Dexamethasone results in increased expression of CS mRNA | 12q13.3 | |
| Dexamethasone | Approved Investigational Vet Approved | CSAD | 51380 |
upregulated | Dexamethasone results in increased expression of CSAD mRNA | 12q13.13 | |
| Dexamethasone | Approved Investigational Vet Approved | CSF2 | 1437 |
downregulated | Dexamethasone results in decreased expression of CSF2 mRNA | 5q31.1 | |
| Dexamethasone | Approved Investigational Vet Approved | CSF3 | 1440 |
upregulated | Dexamethasone results in increased expression of CSF3 mRNA | 17q21.1 | |
| Dexamethasone | Approved Investigational Vet Approved | CSGALNACT2 | 55454 |
downregulated | Dexamethasone results in decreased expression of CSGALNACT2 mRNA | 10q11.21 | |
| Dexamethasone | Approved Investigational Vet Approved | CTSD | 1509 |
downregulated | Dexamethasone results in decreased expression of CTSD mRNA | 11p15.5 | |
| Dexamethasone | Approved Investigational Vet Approved | CTSK | 1513 |
upregulated | Dexamethasone results in increased expression of CTSK mRNA | 1q21.3 | |